Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.745 EUR | +5.20% | +29.14% | -44.10% |
May. 06 | Carmat: progress in ongoing clinical study | CF |
May. 06 | CARMAT Continues to Build on Its Momentum in the EFICAS Study | CI |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Highlights